53
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Autoantibodies and Autoantigens in the Urine of SLE Patients

, , , , , , & show all
Pages 503-514 | Received 27 Jan 2004, Accepted 07 Apr 2004, Published online: 07 Jul 2009

References

  • Tan, EM. (1989) "Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology", Adv. Immunol. 44, 93–151.
  • Stetler, DA., Rose, KM., Wenger, ME., Berlin, CM. and Jacob, S.T. (1982) "Antibodies to distinct polypeptides of RNA polymerase I in sera from patients with rheumatic autoimmune disease", Proc. Natl Acad. Sci. USA 79, 7499–7503.
  • Stetler, D.A., Reichlin, M., Berlin, CM. and Jacob, S.T. (1987) "Autoantibodies against RNA polymerase I in scleroderma and Sjogren's syndrome sera", Biochem. Biophys. Res. Commun. 144, 1296–1302.
  • Stetler, D.A., Sipes, D.E. and Jacob, S.T. (1985) "Anti-RNA polymerase I antibodies in sera of MRL-lpr/lpr and MRL- + 1+ autoimmune mice. Correlation of antibody production with delayed onset of lupus-like disease in MRL- + /+ mice", J. Exp. Med. 162, 1760–1770.
  • Stetler, D.A. and Calvallo, T. (1987) "Anti-RNA polymerase I antibodies: potential role in the induction and progression of murine lupus nephritis", J. Immunol. 138, 2119–2123.
  • Reimer, G., Rose, KM., Scheer, U. and Tan, E.M. (1987) "Autoantibody to RNA polymerase I in scleroderma sera", J. Glitz. Investig. 79, 65–72.
  • Kuwana, M., Kburaki, J., Mimori, T., Tojo, T. and Homma, M. (1993) "Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis", J. Clin. Investig. 91, 1399–1404.
  • Okana, Y, Stee, V. and Medsger, TA. (1993) "Autoantibody reactive with RNA polymerase m in systemic sclerosis", Ann. Intern. Med. 119, 1005–1013.
  • Hirakata, M., Okano, Y, Pati, U., Suwa, A., Medsger, TA., Hardin, LA. and Craft, J. (1993) "Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA Polymerase land IB", J. Glitz. Investig. 91, 2665–2672.
  • Satoh, M., Kuwana, M., Ogasawara, T., Ajmanik, AK., Langdon, J.J., Kimpel, D., Wang, J. and Reeves, W.H. (1994) "Association of autoantibodies to topoisomerase I and the phosphorylated (IO) form of RNA polymerase II in Japanese scleroderma patients", J. Immunol. 153, 5838–5858.
  • Chang, M., Wang, R.J., Uangco, D.T., Sharp, G.C., Komatireddy, G.R. and Hoffman, R.W. (1998) "Analysis of autoantibodies against RNA polymerases using immunoaffinity-purified RNA polymerase I, 11, and BI antigen in an enzyme-linked immunoabsorbent assay", Clin. Immunol. ImmunopathoL 89, 71–78.
  • Kuwana, M., Okano, Y, Kaburald, J., Medsger, TA. and Wright, TM. (1999) "Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes", Arthritis Rheum. 42, 275–284.
  • Kuwana, M., Kimura, K. and Kawakami, Y. (2002) "Identifi-cation of an immunodominant epitope on RNA polymerase BI recognized by systemic sclerosis sera", Arthritis Rheum. 46, 2742–2747.
  • Yamada, A., Miyakawa, Y. and Kosaka, K. (1982) "Entrapment of anti-DNA antibodies in the kidneys of patients with systemic lupus erythematosus", Kidney Int. 22, 671–676.
  • Maryhew, N.L., Messner, R.P. and Tan, EM. (1983) "Urinary excretion of antinuclear antibodies", J. RheumatoL 10, 913–919.
  • Perez-Qazquez, ME., Cabiedes, J., Cabral, AR. and Alarcon-Segovia, D. (1992) "Decrease in serum antiphospholipid antibody[5]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.